Ernst Jung Prize

from Wikipedia, the free encyclopedia

The Ernst Jung Prize is currently endowed with 300,000 euros and has been awarded annually since 1976 for important work in the field of human medicine . It is donated by the Jung Foundation for Science and Research and serves to support further research.

Since 1990, this foundation has also awarded the Ernst Jung Medal for Medicine in Gold , which is awarded to leading researchers or clinicians for their life's work. In 2006, the Ernst Jung career advancement award for medical research was added, an award worth 210,000 euros, which is awarded annually and is aimed at successful young doctors. Doctors who return after at least two years of research abroad to do more in-depth scientific work at a German clinic and at the same time strive for specialist training are eligible.

Winner of the Ernst Jung Prize for Medicine

  • 1976 Donald A. Henderson (Smallpox Eradication Unit, World Health Organization, Geneva) and Lorenz E. Zimmerman (Armed Forces Institute of Pathology, Washington, DC)
  • 1977 Georg F. Springer (Dept. of Immunochemistry Research, Evanston Hospital, Northwestern University, Evanston, Illinois) and John B. West (University of California, San Diego, Institute of Medicine and Bioengineering, Section of Physiology, Department of Medicine, La Jolla, California)
  • 1979 Karl Lennert (Institute for Pathology, Clinic of Christian Albrechts University, Kiel), Anthony GE Pearse (Royal Postgraduate Medical School, University of London, Hammersmith Hospital, London) and Åke Senning (Surgical Clinic A, University Hospital Zurich)
  • 1980 Eberhard Dodt (Max Planck Institute for Physiological and Clinical Research, WG Kerckhoff Institute, Bad Nauheim), Sir Alan Parks (St. Mark's Hospital and London Hospital, London) and Bruno Speck (Kantonsspital Basel, Hematological Department, Basel)
  • 1981 David E. Kuhl (Division of Nuclear Medicine, UCLA School of Medicine, University of California, Los Angeles, California)
  • 1982 Hartmut Wekerle (Max Planck Institute for Immunobiology, Freiburg; MPG Clinical Research Group for Multiple Sclerosis, Würzburg) and Rolf Zinkernagel (Institute for Pathology at the University of Zurich, University Hospital Zurich)
  • 1983 Hans-Jürgen Bretschneider (Center for Physiology and Pathophysiology of the Faculty of Medicine, Georg-August University, Göttingen) and Richard R. Lower (Medical Center of Virginia Commonwealth University, Richmond, Virginia)
  • 1984 George Gee Jackson (Department of Medicine, Section of Infectious Diseases, University of Illinois, College of Medicine, Chicago, Illinois), Werner Franke (Institute for Cell and Tumor Biology, German Cancer Research Center, Heidelberg) and Klaus K. Weber (Max- Planck Institute for Biophysical Chemistry, Karl Friedrich Bonhoeffer Institute, Göttingen-Nikolausberg)
  • 1985 Hendrik Coenraad Hemker (Department of Biochemistry, Rijksuniversiteit Limburg, Maastricht, Netherlands), Rudolf Pichlmayr (Clinic for Abdominal and Transplant Surgery, Hannover Medical School) and Peter K. Vogt (Department of Microbiology, School of Medicine, University of Southern California, Los Angeles, California)
  • 1986 Albrecht Fleckenstein (Physiological Institute, Calcium Antagonism Project Group, Albert Ludwig University, Freiburg i. Br.)
  • 1987 Peter D. Richardson (Division of Engineering, Brown University, Providence, Rhode Island) and Karl Julius Ullrich (Department of Physiology, Max Planck Institute for Biophysics, Frankfurt am Main)
  • 1988 Helmut Sies (Institute for Physiological Chemistry I, University of Düsseldorf) and Charles Weissmann (Institute for Molecular Biology I, University of Zurich)
  • 1989 Thomas F. Budinger (Donner Laboratory at Lawrence Berkeley Laboratory, Berkeley, California) and Jon van Rood (Department of Immunohaematology and Blood Bank, University Hospital Leiden, Netherlands)
  • 1990 Gerhard Giebisch (Department of Cellular and Molecular Physiology, School of Medicine, Yale University, New Haven, Connecticut) and Wilhelm Stoffel (Institute for Biochemistry at the Medical Faculty of the University of Cologne)
  • 1991 David Ho (Aaron Diamond AIDS Research Center of New York and New York University, School of Medicine, New York) and Klaus Starke (Institute for Pharmacology and Toxicology, Albert Ludwig University, Freiburg)
  • 1992 Sir Roy Yorke Calne (University of Cambridge Clinical School, Department of Surgery, Addenbrooke's Hospital, Cambridge) and Martin E. Schwab (Institute for Brain Research, University of Zurich)
  • 1993 Charles Dinarello (Division of Geographic Medecine and Infectious Diseases, Tufts University School of Medecine, Boston, Massachusetts) and Robert Machemer (Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina)
  • 1994 Terence Jones (Royal Postgraduate Medical School, Hammersmith Hospital, London) and Wolf Singer (Max Planck Institute for Brain Research, Frankfurt am Main)
  • 1995 Anthony Fauci (National Institutes of Health, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland) and Samuel A. Wells , Jr. (Department of Surgery, School of Medicine, Washington University, St. Louis, Missouri)
  • 1996 Harald zur Hausen (German Cancer Research Center) and Eberhard Nieschlag (Institute for Reproductive Medicine, Westfälische Wilhelms-Universität, Münster)
  • 1997 Francis V. Chisari (The Scripps Research Institute, La Jolla, California), Hans Hengartner (Department of Pathology, University Hospital Zurich), Judah Folkman (Department of Surgery and Children's Hospital, Harvard Medical School, Boston, Massachusetts)
  • 1998 Alain Fischer (Département de Pédiatrie, Unité D'Immunologie et D'Hématologie, Groupe Hôspitalier Necker - Enfants Malades, Paris)
  • 1999 Adriano Aguzzi (Department of Pathology, University Hospital Zurich) and Hans A. Kretzschmar (Institute for Neuropathology, Georg-August University Göttingen)
  • 2000 Martin Lohse (Institute for Pharmacology and Toxicology, Julius Maximilians University of Würzburg) and Peter H. Krammer (German Cancer Research Center, Heidelberg)
  • 2001 Christine Petit (Unité de Génétique des Déficits Sensoriels, Institut Pasteur, Paris) and Thomas Jentsch (Center for Molecular Neurobiology, University of Hamburg)
  • 2002 Michael Frotscher (Anatomical Institute, Albert Ludwigs University, Freiburg) and Christian Haass (Adolf Butenandt Institute, Ludwig Maximilians University, Munich)
  • 2003 Ari Helenius (Institute for Biochemistry, Eidgenössische Technische Hochschule, Zurich) and Reinhard Lührmann (Max Planck Institute for Biophysical Chemistry, Göttingen)
  • 2004 Stuart A. Lipton (The Burnham Institute, La Jolla, California) and Tobias Bonhoeffer (Max Planck Institute for Neurobiology, Munich-Martinsried)
  • 2005 Ernst Hafen (Zoological Institute / Developmental Biology, University of Zurich) and Franz-Ulrich Hartl (Max Planck Institute for Biochemistry, Munich-Martinsried)
  • 2006 Reinhard Jahn (Max Planck Institute for Biophysical Chemistry, Göttingen) and Markus F. Neurath (I. Medical Clinic and Polyclinic, Johannes Gutenberg University, Mainz)
  • 2007 Andreas Zeiher and Stefanie Dimmeler , two cardiologists from the Frankfurt University Hospital, and the Viennese molecular biologist Josef Penninger
  • 2008 Thomas Benzing (Director of Clinic IV for Internal Medicine: Nephrology and General Internal Medicine, University Clinic Cologne), Gerd Walz (Director of Medical Clinic IV, Nephrology and General Medicine, University Clinic Freiburg) and Thomas Tuschl (Rockefeller University, USA)
  • 2009 Jens Claus Brüning (Institute for Genetics, University of Cologne) and Patrick Cramer (Gene Center Munich Ludwig Maximilians University, Munich)
  • 2010 Stephen G. Young (Department of Medicine, University of California, Los Angeles) and Peter Carmeliet (Vesalius Research Center, University of Leuven)
  • 2011 Hans Clevers (Hubrecht Institute, Utrecht) and Christian Büchel (Institute for Systemic Neurosciences, University Medical Center Hamburg-Eppendorf)
  • 2012 Peter Walter (Howard Hughes Medical Institute, San Francisco) and Elisa Izaurralde (Max Planck Institute for Developmental Biology )
  • 2013 Angelika Amon (Howard Hughes Medical Institute of the Massachusetts Institute of Technology) and Ivan Dikic (Frankfurt Goethe University and Buchmann Institute for Molecular Life Sciences)
  • 2014 Thomas Boehm (Max Planck Institute for Immunobiology and Epigenetics, Freiburg)
  • 2015 Emmanuelle Charpentier (Helmholtz Center for Infection Research, Braunschweig, and Hannover Medical School)
  • 2016 Hans-Georg Rammenee (University of Tübingen)
  • 2017 Tobias Moser (University Medical Center Göttingen) and Nenad Ban (Department of Biology at ETH Zurich)
  • 2018 Marco Prinz (University Medical Center Freiburg) and Ruth Ley (Max Planck Institute for Developmental Biology)
  • 2019 Gary R. Lewin (Max Delbrück Center for Molecular Medicine) and Brenda A. Schulman (Max Planck Institute for Biochemistry)

Winner of the Ernst Jung Medal for Medicine in Gold

Winner of the Ernst Jung career advancement award for medical research

  • 2006 Jan Wehkamp, ​​Stuttgart
  • 2007 Jörg Distler, Erlangen
  • 2008 Tom Lüdde, Aachen
  • 2009 Florian Mormann, Bonn
  • 2010 Annett Halle, Berlin
  • 2011 Stefan Schrader, London
  • 2012 Samuel Huber, Hamburg
  • 2013 Anita Kremer, Erlangen
  • 2014 Thomas Schmidt, Heidelberg
  • 2015 Behzad Kharabi Masouleh, Aachen
  • 2016 Sebastian Kobold, Munich
  • 2017 Lena Seifert, Dresden
  • 2018 Till Schoofs, Cologne
  • 2019 Sebastian Zundler, Erlangen

Web links

Footnotes

  1. ↑ a b c Jung Foundation for Science and Research awards medicine prizes 2019 in Hamburg. Retrieved May 23, 2019 .